🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

Decision Sciences eyes debt raise to fund the building of border security AI tech

Share

News and Analysis

Decision Sciences eyes debt raise to fund the building of border security AI tech

Mary Ellen Cagnassola's avatar
  1. Mary Ellen Cagnassola
•3 min read

Don’t miss out on news you won’t find anywhere else — get The Memo US and The Memo Europe in your inbox every two weeks.

Decision Sciences International Corporation is tapping the debt market in order to secure a refinancing, increase its liquidity, and fund the building of its AI-powered cargo inspection scanning systems as the US ramps up border security efforts, according to documents obtained by 9fin.

As at August 2025, Decision Sciences was seeking senior debt of between $75m-$100m in size, which would replace its existing $45m debt and provide at least $30m to fund working capital. The company is expecting a firm order from US Customs and Border Patrol before the year end, according to the documents.

The expected interest accrual for the senior debt package for Decision Sciences is 12% when cash pay and 15% when PIK, with warrants, per the documents.

The package would include warrants for underlying private common stock. Meanwhile, certain events — such as the sale of medical company affiliate Decision Science Medical in which Decisions Sciences owns 65% with proceeds greater than $100m — would create a premium multiple on investment capital and take out existing debt.

What are you waiting for?

Try it out
  • We're trusted by the top 10 Investment Banks